← Back to Clinical Trials
Recruiting NCT07707102

NCT07707102 Advancing Skills Through Consultation, Education, and Novel Technologies

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07707102
Status Recruiting
Phase
Sponsor The University of Texas Health Science Center at San Antonio
Condition PTSD - Post Traumatic Stress Disorder
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2026-08-20
Primary Completion 2028-08-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Live workshopAI-enhanced Web-based trainingConsultation video calls

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 300 participants in total. It began in 2026-08-20 with a primary completion date of 2028-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research study tests strategies to train behavioral health providers in Written Exposure Therapy (WET), an evidence-based treatment for posttraumatic stress disorder (PTSD). There are a number of evidence-based treatments for posttraumatic stress disorder (PTSD). However, most behavioral health providers have not received training in these PTSD treatments and do not offer them regularly to their patients. The researchers hope to learn about the optimal way to train behavioral providers in this type of treatment. This study is designed to determine the comparative effectiveness of different training strategies on key outcomes such as how much competency providers develop in the therapy and to how many patients they deliver the therapy. This study will help the researchers understand if we can help more providers learn to competently delivery Written Exposure Therapy by using strategies that are more convenient and cost less money, including web-based and AI-facilitated training supports. This study will also help us learn which training strategies work best for which providers so that in the future we can make personalized training recommendations.

Eligibility Criteria

Inclusion Criteria: 1. mental health provider; 2. serves veterans and/or service members with PTSD (by self-report); 3. willing to participate in either live or web-based training. Exclusion Criteria: 1\. has already completed formal training in Written Exposure Therapy

Contact & Investigator

Central Contact

Stefanie Losavio, PhD

✉ ASCENT@uthscsa.edu

📞 (210) 562-6714

Principal Investigator

Stefanie LoSavio, PhD

PRINCIPAL INVESTIGATOR

The University of Texas Health Science Center at San Antonio

Frequently Asked Questions

Who can join the NCT07707102 clinical trial?

This trial is open to participants of all sexes, studying PTSD - Post Traumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07707102 currently recruiting?

Yes, NCT07707102 is actively recruiting participants. Contact the research team at ASCENT@uthscsa.edu for enrollment information.

Where is the NCT07707102 trial being conducted?

This trial is being conducted at San Antonio, United States.

Who is sponsoring the NCT07707102 clinical trial?

NCT07707102 is sponsored by The University of Texas Health Science Center at San Antonio. The principal investigator is Stefanie LoSavio, PhD at The University of Texas Health Science Center at San Antonio. The trial plans to enroll 300 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology